Biocytogen
About Company
Biocytogen provides integrated solutions for next-generation antibody drug development to the global biomedical communities. Powered by cutting-edge gene editing technologies and a state-of-the-art animal facility, Biocytogen developed a seamlessly integrated platform for efficient antibody drug discovery and validation, including animal model generation, therapeutic antibody discovery (via RenMab™ mice), and in vivo/in vitro preclinical validation studies. Biocytogen collaborates with more than 70% of the top 50 pharmaceutical and biotechnology companies worldwide. Together, we discover innovative medicines for a better, healthier world.
Business Industry
Other, Preclinical Services, Animal Models, Gene Targeting, Antibody Research, Development, Animal Production, Breeding, In Vivo Study, Fully Human Antibody Mouse, Antibody Discovery, Preclinical Cro, Pharmacology, Antibody Licensing
